Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28350
Full metadata record
DC FieldValueLanguage
dc.contributor.authorReck, M-
dc.contributor.authorCiuleanu, T-E-
dc.contributor.authorCobo, M-
dc.contributor.authorSchenker, M-
dc.contributor.authorZurawski, B-
dc.contributor.authorMenezes, J-
dc.contributor.authorRichardet, E-
dc.contributor.authorBennouna, J-
dc.contributor.authorFelip, E-
dc.contributor.authorJuan-Vidal, O-
dc.contributor.authorAlexandru, A-
dc.contributor.authorSakai, H-
dc.contributor.authorLingua, A-
dc.contributor.authorReyes, F-
dc.contributor.authorSouquet, P-J-
dc.contributor.authorDe Marchi, P-
dc.contributor.authorMartin, C-
dc.contributor.authorPérol, M-
dc.contributor.authorScherpereel, A-
dc.contributor.authorLu, S-
dc.contributor.authorPaz-Ares, L-
dc.contributor.authorCarbone, D P-
dc.contributor.authorMemaj, A-
dc.contributor.authorMarimuthu, S-
dc.contributor.authorZhang, X-
dc.contributor.authorTran, P-
dc.contributor.authorJohn, Thomas-
dc.date2021-12-02-
dc.date.accessioned2021-12-14T03:13:03Z-
dc.date.available2021-12-14T03:13:03Z-
dc.date.issued2021-12-02-
dc.identifier.citationESMO Open 2021; 6(6): 100345en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/28350-
dc.language.isoeng
dc.titleCorrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273].en
dc.typeJournal Articleen
dc.identifier.journaltitleESMO Openen
dc.identifier.affiliationMedical Oncologyen
dc.identifier.affiliationDepartment of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, LungClinic, Grosshansdorf, Germany. Electronic address: m.reck@lungenclinic.deen
dc.identifier.affiliationDepartment of Oncology, Institutul Oncologic Prof Dr Ion Chiricuta and UMF Iuliu Hatieganu, Cluj-Napoca, Romaniaen
dc.identifier.affiliationDepartment of Medical Oncology, Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spainen
dc.identifier.affiliationDepartment of Oncology, SF Nectarie Oncology Center, Craiova, Romaniaen
dc.identifier.affiliationDepartment of Clinical Oncology, Ambulatorium Chemioterapii, Bydgoszcz, Polanden
dc.identifier.affiliationDepartment of Oncology, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazilen
dc.identifier.affiliationDepartment of Clinical Oncology, Instituto Oncológico de Córdoba, Córdoba, Argentinaen
dc.identifier.affiliationDepartment of Thoracic Oncology, University Hospital of Nantes and INSERM, CRCINA, Nantes, Franceen
dc.identifier.affiliationDepartment of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spainen
dc.identifier.affiliationDepartment of Medical Oncology, Hospital Universitario La Fe, Valencia, Spainen
dc.identifier.affiliationDepartment of Oncology, Institute of Oncology Prof Dr Alexandru Trestioreanu Bucha, Bucharest, Romaniaen
dc.identifier.affiliationDepartment of Thoracic Oncology, Saitama Cancer Center, Saitama, Japanen
dc.identifier.affiliationDepartment of Medical Oncology, Instituto Medico Rio Cuarto, SA, Córdoba, Argentinaen
dc.identifier.affiliationDepartment of Medical Oncology, Fundación Arturo López Pérez, Santiago, Metropolitana, Chileen
dc.identifier.affiliationDepartment of Pneumology, Hôpital Lyon Sud, Lyon, Pierre Bénite, Franceen
dc.identifier.affiliationDepartment of Oncology, Barretos Cancer Hospital, Barretos, Brazilen
dc.identifier.affiliationDepartment of Thoracic Oncology, Instituto Alexander Fleming, Buenos Aires, Argentinaen
dc.identifier.affiliationDepartment of Thoracic Oncology, Léon Bérard Cancer Center, Lyon, Franceen
dc.identifier.affiliationDepartment of Pulmonary and Thoracic Oncology, University of Lille, CHU Lille, INSERM U1189, OncoThAI, Lille, Franceen
dc.identifier.affiliationDepartment of Medical Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai JiaoTong University, Shanghai, Chinaen
dc.identifier.affiliationDepartment of Medical Oncology, Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Clinical Research Unit, Universidad Complutense & CiberOnc, Madrid, Spainen
dc.identifier.affiliationDepartment of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USAen
dc.identifier.affiliationBristol Myers Squibb, Princeton, USAen
dc.identifier.doi10.1016/j.esmoop.2021.100345en
dc.type.contentTexten
dc.identifier.pubmedid34864501
local.name.researcherJohn, Thomas
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptMedical Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

26
checked on Nov 3, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.